Galapagos
Europe, Limburg, Belgium, Mechelen-bovelingen
Description
Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel.
Investor Profile
Galapagos has made 3 investments, with 1 in the past 12 months and 0% as lead.
Stage Focus
- Seed (67%)
- Series C (33%)
Country Focus
- United States (33%)
- The Netherlands (33%)
- France (33%)
Industry Focus
- Biotechnology
- Life Science
- Biopharma
- Pharmaceutical
- Precision Medicine
- Health Care
- Therapeutics
- Health Diagnostics
- Medical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
